In DLBCL, p53 can directly bind to the promoter region of the lncRNA PANDA, which inactivates the MAPK/ERK signaling pathway, suppressing the proliferation of DLBCL cells by a G0/G1 cell-cycle arrest [75]. Here, MAPK1 is linked to diffuse large B-cell lymphoma.